{"id":"W1966163121","doi":"10.1111/jdv.12943","title":"Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab","year":2015,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dermatrials Research; Lynde Centre for Dermatology; Merck Canada Inc. (Canada); Innovaderm (Canada)","funders":"Janssen Biotech; LEO Pharma; AbbVie; Celgene; Novartis; Pfizer; Amgen","keywords":"Adalimumab; Medicine; Infliximab; Etanercept; Psoriasis; Internal medicine; Tumor necrosis factor alpha; Gastroenterology; Surgery; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000938322,0.0001950821,0.0007315344,0.0003207047,0.0003755297,0.0004617207,0.0001808738,0.0003637803,0.001798485],"category_scores_gemma":[0.001124321,0.0001149862,0.000679487,0.000398394,0.0001730436,0.0002576033,0.0001828768,0.0004806323,0.0002588019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002587358,"about_ca_system_score_gemma":0.0003822783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000264288,"about_ca_topic_score_gemma":0.0006207571,"domain_scores_codex":[0.9995491,0.0001809694,0.00006429241,0.00005866296,0.00007110286,0.0000757997],"domain_scores_gemma":[0.9992847,0.000253048,0.0002335652,0.0000299597,0.00005261121,0.0001460947],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04116026,0.001741002,0.7158932,0.001901334,0.001510072,0.007776146,0.0005425768,0.0005745282,0.009419768,0.0003622181,0.003907276,0.2152117],"study_design_scores_gemma":[0.01478182,0.02932649,0.8683329,0.0008027473,0.001731846,0.04998983,0.0005387136,0.002183485,0.003663807,0.0006454568,0.02794214,0.00006082845],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980644,0.01493747,0.0004230799,0.0004568468,0.0001010224,0.0002250033,0.0002235182,0.00002149924,0.002967619],"genre_scores_gemma":[0.995911,0.002048372,0.0003161408,0.0005822605,0.00008834075,0.0001213952,0.0001906892,0.00000280086,0.0007390898],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001798485,"threshold_uncertainty_score":0.006016493,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03392926498281086,"score_gpt":0.2660513269078753,"score_spread":0.2321220619250644,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}